Aurobindo Pharma Limited has received the tentative approval to manufacture and market Losartan potassium tablets in the strengths 25mg, 50mg and 100mg from the US Food & Drug Administration.
Losartan potassium tablets are the generic equivalent of Merck Research Laboratories Cozaar tablets 25mg, 50mg and 100mg and falls in the anti-hypertensive segment. The branded sales of Losartan range of products was USD 1235 million for the year ended December 2007 according to Merck financial disclosures. This is the Aurobindo's 75th ANDA approval from US FDA.
Aurobindo Pharma Limited headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients.